Neovacs SA
F:0LW0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Neovacs SA
F:0LW0
|
FR |
|
EKF Diagnostics Holdings PLC
F:LYF
|
UK |
|
mPay SA
F:8NJ
|
PL |
|
C
|
Ceres Ventures Inc
OTC:CEVE
|
US |
|
Biorem Inc
XTSX:BRM
|
CA |
|
Fission 3.0 Corp
XTSX:FUU
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0LW0's stock price target?
Not Available
0LW0 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Neovacs SA?
Projected CAGR
25%
The compound annual growth rate for Revenue over the next 8 years is 25%.